Science · 1998 · 90 citations · 15 references
Life SciencesImmunologyMolecular BiologyAutoimmunityCellular ImmunologyImmunopathologyAutoantibodiesAutoimmune Disease PathogenesisAutoimmune Disease PathologyAutoimmune DiseasesAutoimmune PathogenesisConstitutive Expression SystemsConstitutive Gene ExpressionFas LigandPrimary CellsT Cell CytotoxicityThyroid AutoantibodiesThyroid AutoimmunityThyroid Follicular Cell Biology
C. Giordano et al. (1) reported evidence that the ligand for Fas antigen (FasL) is constitutively expressed on thyroid follicular cells from both normal and Hashimoto's thyroiditis (HT) tissue, and that normal thyrocytes express Fas antigen only after induction with interleukin-1β (IL-1β). Giordano et al. conclude that their results suggested a possible mechanism for thyrocyte cytotoxicity in autoimmune thyroiditis. The absence of Fas antigen expression on the surface of normal thyrocytes has been supported by one study (2); however, other studies have found Fas expression by normal thyrocytes both in situ (3) and in primary cultured cells (4,5). The findings by Giordano et al. raised the possibility of the expression of both Fas antigen and FasL on normal thyrocytes. To clarify this issue, we examined the expression of both FasL and Fas antigen mRNA in primary cultured thyrocytes with the use of reverse-transcriptase polymerase chain reaction (RT-PCR) (6) and ribonuclease protection (7) techniques. Neither assay, performed on RNA isolated from normal human thyrocytes, demonstrated mRNA for FasL (Fig. 1, A and B). To assure that this result was not unique to this sample, RNA samples from five different normal and Graves's diseased thyrocytes were screened by ribonuclease protection assay; these also did not show mRNA for FasL (Fig. 1C). In contrast, Fas antigen mRNA was detected in all five specimens (Fig. 1C) and has also been detected by RT-PCR (5). Treating the thyroid cells with TSH, IL-1β, or γINF for up to 48 hours (before harvest and RNA isolation) also did not induce the expression of FasL mRNA or alter the expression of Fas antigen mRNA.
15
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Michael Hahne, Donata Rimoldi, Michael Schröter et al. · Science · 1996 · 1.3K citations
Life Sciences, Immunology, Oncology +17
Metalloproteinase-mediated release of human Fas ligand.
Nobuhiko Kayagaki, Tomohiko Ebata, Hiroshi Ohmoto et al. · The Journal of Experimental Medicine · 1995 · 831 citations · Full text
Life Sciences, Immunology, Pathology +15
Downregulation of Fas ligand by shedding
Masato Tanaka, Toshimitsu Itai, Masashi Adachi et al. · Nature Medicine · 1998 · 675 citations
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Masato Tanaka, Takashi Suda, Takayuki Takahashi et al. · The EMBO Journal · 1995 · 652 citations · Full text
Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection
Winston Cavert, Daan W. Notermans, Katherine Staskus et al. · Science · 1997 · 630 citations · Full text